| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/08/1997 | US5646167 Arylsulfonamido-substituted hydroxamix acids |
| 07/08/1997 | US5646166 Use of 5-acyl-1,4-dihydropyridines |
| 07/08/1997 | US5646163 Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| 07/08/1997 | US5646162 Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents |
| 07/08/1997 | US5646161 Side effect reduction; sustained release |
| 07/08/1997 | US5646160 Method of treating hyperproliferative vascular disease with rapamycin and mycophenolic acid |
| 07/08/1997 | US5646159 Water-soluble esters of camptothecin compounds |
| 07/08/1997 | US5646158 For treating allergic and inflammatory diseases and for inhibiting the production of tumor necrosis factor |
| 07/08/1997 | US5646156 Administering xanthine derivative as antiinflammatory agent or antiallergen |
| 07/08/1997 | US5646155 Drugs to prevent recurrent herpes virus infections |
| 07/08/1997 | US5646154 Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor |
| 07/08/1997 | US5646153 Inhibiting abnormal cell proliferation |
| 07/08/1997 | US5646152 Treating psychological disorders with corticotropin releasing factor antagonists |
| 07/08/1997 | US5646151 For treatment of hyperalgesia |
| 07/08/1997 | US5646150 Methods of using lavendamycin analogs |
| 07/08/1997 | US5646149 Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 07/08/1997 | US5646148 Piperazinylbenzofuran derivatives |
| 07/08/1997 | US5646146 Heterocyclic compounds and their preparation and use |
| 07/08/1997 | US5646144 For treating disorders in which substance p plays a part in development |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | US5646141 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/08/1997 | US5646140 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity |
| 07/08/1997 | US5646139 Antimicrobial carbapenem quinolones |
| 07/08/1997 | US5646138 Prevention of inflammatory or allergic reactions, treatment of cardiovascular or haemodynamic disorders |
| 07/08/1997 | US5646137 Administering antiestrogen, i.e. raloxifene, and a progestin |
| 07/08/1997 | US5646136 Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
| 07/08/1997 | US5646135 Method for controlling coccidiosis |
| 07/08/1997 | US5646134 Inhibiting bone resorption |
| 07/08/1997 | US5646132 2(1H)-quinolone compounds |
| 07/08/1997 | US5646130 Low molecular weight sulfated polysaccharides and uses thereof |
| 07/08/1997 | US5646129 Exposing mesenchymal cells to hyaluronic acid |
| 07/08/1997 | US5646128 Treating inflammation, sepsis, septic shock, burns |
| 07/08/1997 | US5646127 Treatment with oligodeoxyribonucleotide |
| 07/08/1997 | US5646125 Polysubstituted benzimidazoles as antiviral agents |
| 07/08/1997 | US5646124 Method of treating cancer by conjunctive therapy with N,N'-bis[3-(ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent |
| 07/08/1997 | US5646118 Glutamine, fatty acid, insulin-like growth factors |
| 07/08/1997 | US5646109 Convertible microemulsion formulations |
| 07/08/1997 | US5646042 C-myb targeted ribozymes |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5645999 Assays for compounds that modulate or alter cyclin E activity |
| 07/08/1997 | US5645988 Methods of identifying drugs with selective effects against cancer cells |
| 07/08/1997 | US5645985 Used for diagnosis to detect viruses or diseased conditions |
| 07/08/1997 | US5645857 Pharmaceutical composition having analgesic activity |
| 07/08/1997 | US5645852 Butyric ester cyto-differtiating agents |
| 07/08/1997 | US5645829 Mesothelial cell gene therapy |
| 07/08/1997 | US5645826 Method of treating damaged tissue with semi-occlusive salicylic acid ointment |
| 07/08/1997 | US5645825 Depilatory compositions comprising sulfhydryl compounds |
| 07/08/1997 | US5645819 Methods of diagnosing and treating an intestinal and lung roundworm infection |
| 07/08/1997 | CA2127878C Fo-1289 substance and its production |
| 07/08/1997 | CA2081970C Hiv protease inhibitors useful for the treatment of aids |
| 07/08/1997 | CA2057913C N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 07/08/1997 | CA2005811C Cosmetic composition |
| 07/06/1997 | CA2186542A1 Composition and method for delivery of nucleic acids |
| 07/03/1997 | WO1997023783A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
| 07/03/1997 | WO1997023637A1 Galactopyranosides and their use |
| 07/03/1997 | WO1997023628A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | WO1997023625A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023611A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof |
| 07/03/1997 | WO1997023510A1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs |
| 07/03/1997 | WO1997023508A1 Compounds with growth hormone releasing properties |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023499A1 Prodrugs of thrombin inhibitors |
| 07/03/1997 | WO1997023495A1 Water soluble antibiotics |
| 07/03/1997 | WO1997023494A1 Carbohydrate conjugated bio-active compounds |
| 07/03/1997 | WO1997023485A1 Heteroarylcarboxamide derivatives |
| 07/03/1997 | WO1997023482A1 2,7-substituted octahydro-pyrrolo[1,2-a]pyrazine derivatives |
| 07/03/1997 | WO1997023481A1 Trans apovincaminic acid ester derivatives as drugs |
| 07/03/1997 | WO1997023480A1 Novel integrin receptor antagonists |
| 07/03/1997 | WO1997023478A1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/03/1997 | WO1997023477A1 Dibenzothiepin derivatives and pharmaceutical compositions |
| 07/03/1997 | WO1997023476A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER |
| 07/03/1997 | WO1997023473A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 07/03/1997 | WO1997023472A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 07/03/1997 | WO1997023470A1 Biologically active benzothiazolone ethanamines |
| 07/03/1997 | WO1997023467A1 Novel compounds with analgesic effect |
| 07/03/1997 | WO1997023466A1 Novel compounds with analgesic effect |
| 07/03/1997 | WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/03/1997 | WO1997023464A1 Phenylimidazolidines and use thereof as an antiandrogenic agent |
| 07/03/1997 | WO1997023462A1 Quinoline and quinazoline compounds useful in therapy |
| 07/03/1997 | WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023456A1 Indoloquinone derivatives as bioreductive agents |
| 07/03/1997 | WO1997023453A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 07/03/1997 | WO1997023451A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | WO1997023447A1 N-acylaminoalkylhydrazinecarboximidamides |
| 07/03/1997 | WO1997023256A1 Localized intravascular delivery of growth factors for promotion of angiogenesis |
| 07/03/1997 | WO1997023243A1 Branched hydrazone linkers |
| 07/03/1997 | WO1997023242A1 Pharmaceutical compositions with vitamin d analogues |
| 07/03/1997 | WO1997023240A2 Conjugate comprising an active agent, a polypeptide and a polyether |
| 07/03/1997 | WO1997023238A1 Stabilisers for live vaccines |
| 07/03/1997 | WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |